Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia



Rating:

Share or cite this content

Citations should be made in the following way:
O. Caguana Velez (Barcelona, Spain), D. Badenes (Barcelona, Spain), F. Zuccarino (Barcelona, Spain), L. Del Carpio Bellido (Barcelona, Spain), D. Rodríguez-Chiaradía (Barcelona, Spain), M. Domínguez (Barcelona, Spain), J. Gea (Barcelona, Spain), E. Balcells (Barcelona, Spain). FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION. 3289

Member's Comments

No comment yet.

Related content which might interest you: UTILITY OF BRONCHOALVEOLAR LAVAGE(BAL) TO DETECT INFECTIOUS COMPLICATIONS IN PATIENTS WITH SEVERE SARS-COV-2 PNEUMONIA Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021 SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA Source: International Congress 2018 – New modalities in asthma treatment Year: 2018 ONE YEAR MORTALITY IN PATIENTS WITH PNEUMOCOCCAL BACTERAEMIC COMMUNITY ACQUIRED PNEUMONIA: ROLE OF THREE PNEUMONIA SEVERITY SCORES Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 LONG –TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL AND LEGIONELLA PNEUMONIA Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY. Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis? Year: 2020 LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension Year: 2020 PLEURAL EFFUSION IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 LYMPHOPENIA AS PREDICTOR OF LONG TERM MORTALITY IN PATIENTS WITH HOSPITAL ACQUIRED PNEUMONIA Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018 QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS Source: Virtual Congress 2020 – Organising respiratory disease management in primary care Year: 2020 DIAGNOSTICS, THERAPY, COURSE AND RESULTS IN PATIENTS WITH CHRONIC EXTRINSIC ALLERGIC ALVEOLITIS. Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 AWAKE PRONE POSITION IN CRITICAL AND SEVERE COVID-19 PATIENTS UNDERGOING NONINVASIVE RESPIRATORY SUPPORT: A RETROSPECTIVE MULTICENTER COHORT STUDY. Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 RISK FACTORS FOR LONG-TERM MORTALITY IN PATIENTS WITH PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights Year: 2019 A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation Year: 2018 SYSTEMIC INFLAMMATION IN PATIENTS WITH STABLE NON-CYSTIC FIBROSIS BRONCHIECTASIS Source: Virtual Congress 2021 – Bronchiectasis Year: 2021 PREVALENCE AND CHARACTERISTICS OF SAHS PATIENTS ADMITTED FOR COVID-19 PNEUMONIA Source: Virtual Congress 2021 – Sleep across the lifespan in the new era of COVID - 19 Year: 2021 ANALYSIS OF INITIAL NON-CONCLUSIVE THORACOSCOPIES WITH A DIAGNOSIS OF MALIGNANCY OBTAINED DURING LONG-TERM FOLLOW-UP OF RECURRENT EXUDATIVE PLEURAL EFFUSIONS Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Source: Virtual Congress 2020 – Prognosis and integrated management of COPD Year: 2020